|
1. |
Foreword |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 1-2
Preview
|
PDF (402KB)
|
|
ISSN:0254-4962
DOI:10.1159/000284085
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
2. |
Trazodone, a New Avenue in the Treatment of Depression |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 3-14
Bruno Silvestrini,
Pacifico Valeri,
Preview
|
PDF (2118KB)
|
|
摘要:
Pharmacological and biochemical data on trazodone are reviewed in order to compare this drug to imipramine and other tricyclics both from the point of view of the mechanism of action and preferential clinical indications. Trazodone tends to inhibit biochemical and pharmacological functions depending on the catecholaminergic system, whereas imipramine has a potentiating activity. However, both these drugs decrease the density of β-receptors following repeated administrations. Trazodone and imipramine have similar effects on the serotoninergic system. The two drugs also share an antinociceptive activity. It is stressed that this activity has been of critical importance in the discovery of trazodone. In fact, the development of this drug was based on the working hypothesis that a disturbance in the perception of unpleasant experience has a role in the pathogenesis of depression. Some medical implications of the α-blocking activity of trazodone are discussed. Trazodone is preferable to other antidepressant treatment when depression is associated with angle-closure glaucoma, cardiovascular disturbances depending on noradrenaline release, tremor, some psychotic conditions and alcoholis
ISSN:0254-4962
DOI:10.1159/000284086
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
3. |
Trazodone in Major Affective Disorders |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 15-23
John P. Feighner,
Preview
|
PDF (2260KB)
|
|
摘要:
In summary, on the basis of our inpatient and outpatient double-blind control trials and open-label experience with trazodone, we find it to be an effective broad-spectrum antidepressant generally well tolerated by most patients. When atropine side effects of the standard tricyclic antidepressants and bridged tricyclic antidepressants are undesirable and medically contraindicated, trazodone should be one of the drugs of choice in major depressive disorders.
ISSN:0254-4962
DOI:10.1159/000284088
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
4. |
Trazodone and Mianserin in General Practice |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 24-29
G. Beaumont,
M. Gringras,
S.I. Ankier,
Preview
|
PDF (1784KB)
|
|
摘要:
In a double-blind, noncrossover study, general practice patients suffering from depression were treated with either trazodone (100–200 mg, nocte) or mianserin (60–120 mg, nocte) for 6 weeks. For entry into the study, a minimum score of 14 on the 17-point Hamilton Depression Rating Scale (HDRS) was necessary. By random allocation, 125 patients (61 on trazodone and 64 on mianserin) entered the study. Altogether there were 43 withdrawals, of whom 31 (72%) had received mianserin. At least one of the reasons for 22 withdrawals from the mianserin group was an unacceptable side effect, frequently being daytime drowsiness. In contrast, only 5 of the trazodone group withdrew because of side effects. These differences in the withdrawal rates for those patients entering the study were statistically significant (p < 0.001). A total of 82 patients completed treatment and entered the analysis for efficacy; 49 on trazodone and 33 on mianserin. Results show that both treatments were equally effective in reducing symptoms of depression and anxiety. Thus, the mean HDRS score was 21.3 and 21.5 for trazodone and mianserin, respectively, at the start of treatment which decreased to 6.2 and 5.9, respectively, at the end of 6 weeks. The mean Zung self-rating anxiety scores for trazodone and mianserin were 45.6 and 44.4 at the start of treatment and 33.6 and 31.1 at the end of the study. The results suggest that, on the basis of fewer significant side effects, trazodone is more acceptable to mianserin in treating depression, with or without anxiety, in general practice patie
ISSN:0254-4962
DOI:10.1159/000284089
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
5. |
Experiences with Doxepin and Trazodone in the Therapy with Outpatients Suffering from Depression |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 30-36
Walter Pöldinger,
Preview
|
PDF (2032KB)
|
|
摘要:
In a double-blind study on 40 outpatients (20 per group) suffering from endogenous and psychogenic depression of the anxious-agitated or inhibited form, trazodone was compared with doxepin to determine their efficacy and safety, and whether a single daily administration was adequate. Increasing doses of trazodone 50–200 mg and doxepin 25–100 mg were given once a day in the evening for a period of 5 weeks. Both drugs were found to be approximately equivalent as far as their antidepressive and anxiolytic effects and safety are concerned. Treatment with trazodone promises less risks according to the clinical experience described in the international literature. Administration once a day provides sufficient efficacy and saf
ISSN:0254-4962
DOI:10.1159/000284090
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
6. |
A Double-Blind Study to Compare Trazodone with Amitriptyline in Depressed Patients |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 37-38
P.A. Carney,
D. Healy,
B.E. Leonard,
Preview
|
PDF (446KB)
|
|
ISSN:0254-4962
DOI:10.1159/000284091
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
7. |
Comparative Side Effect Profiles of Trazodone and Imipramine: Special Reference to the Geriatric Population |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 39-50
Samuel Gershon,
Preview
|
PDF (1902KB)
|
|
摘要:
Side effects are a concomitant of almost all therapeutic agents and are also present as part of the pharmacological profile of psychotropic agents. However, the laboratory pharmacological characteristics of agents are a more reliable predictor of side effect profiles than they are of their therapeutic activities. Therefore, it would seem possible to be able to predict with much greater accuracy the clinically significant side effects that may be encountered from the preclinical data. This has been established in the case of trazodone and imipramine. The anticholinergic profile of imipramine was clearly determined in the laboratory and in man it produces a range of activity varying from mild peripheral anticholinergic activity to impairment of various functions involving vision, cardiovascular function and gastrointestinal activity. However, in the geriatric population, because of the vast amount of research implicating cholinergic mechanisms in memory functions and particularly in some aspects of cognitive deficit, it may be predicted that the anticholinergic activity of the tricyclics may present an especially troublesome pattern in a geriatric population that requires antidepressant therapy. These comparative effects between the two agents will be discussed and documented from control study data.
ISSN:0254-4962
DOI:10.1159/000284092
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
8. |
Development of a New Shortened Version of Raven’s Matrices Test for Application Rough Assessment of Present Intellectual Capacity within Psychopathological Investigation |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 49-58
R. Wytek,
E. Opgenoorth,
O. Presslich,
Preview
|
PDF (2350KB)
|
|
摘要:
Based on a sample of 300 psychiatric patients the items of the Standard Progressive Matrices test are analyzed in terms of classical and probabilistic methods, and a version shortened to 30 items is developed. This new version of the test is then standardized from a new sample of 1,200 patients. A table of selected percentiles is computed. Validation with respect to rough classification of intelligence is proved by comparison with results of the WIP.
ISSN:0254-4962
DOI:10.1159/000284003
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
9. |
The Role of Trazodone in the Treatment of Depressed Cardiac Patients |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 51-63
Jonathan M. Himmelhoch,
Kenneth Schechtman,
Ralph Auchenbach,
Preview
|
PDF (2478KB)
|
|
摘要:
The novel antidepressant trazodone is hypothesized to be less cardiotoxic than the tri-tetracyclic antidepressants. Recently, however, 2 patients with preexisting ventricular irritability showed an increased number of ventricular premature beats and of repetitive forms after starting on trazodone. Data are presented here from four studies on the cardiovascular safety of trazodone. Conclusions are: (1) Trazodone has little effect on cardiac conduction. (2) Trazodone does not worsen supraventricular arrhythmias. (3) Trazodone produces less postural hypotension than most other antidepressants and it tends to lower heart rate. (4) Lower doses of trazodone (100–300 mg) are better tolerated and more effective in major depressives simultaneously debilitated by significant cardiovascular disease. (5) It is possible that the so-called ‘trazodone aggravation’ of ventricular irritability is a statistical artifact – although further research is needed to verify this conclusion, and in the meantime the drug should be used with caution in such p
ISSN:0254-4962
DOI:10.1159/000284093
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
10. |
Confirmation of the Borderline Personality within a Psychodynamic Framework |
|
Psychopathology,
Volume 17,
Issue 2,
1984,
Page 59-66
William N. Goldstein,
Preview
|
PDF (2632KB)
|
|
摘要:
Using a psychodynamic framework and an underlying structural configuration, the borderline patient is described. Statistical methods are then used to differentiate this group from both a schizophrenic and a character disorder group of patients. The borderline group emerges as a clear-cut entity characterized by (1) the lack of an integrated self concept, and (2) a particular ego structure consisting of a specific pattern of superficial ego strengths and underlying ego weaknesses.
ISSN:0254-4962
DOI:10.1159/000284004
出版商:S. Karger AG
年代:1984
数据来源: Karger
|
|